Gsg Advisors LLC Cor Medix Inc. Transaction History
Gsg Advisors LLC
- $345 Billion
- Q2 2025
A detailed history of Gsg Advisors LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Gsg Advisors LLC holds 16,000 shares of CRMD stock, worth $179,200. This represents 0.06% of its overall portfolio holdings.
Number of Shares
16,000
Previous 22,000
27.27%
Holding current value
$179,200
Previous $154 Million
28.0%
% of portfolio
0.06%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding CRMD
# of Institutions
181Shares Held
32.7MCall Options Held
867KPut Options Held
561K-
Vanguard Group Inc Valley Forge, PA4.33MShares$48.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$39.8 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.58MShares$28.9 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.71MShares$19.2 Million0.0% of portfolio
-
State Street Corp Boston, MA1.6MShares$17.9 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $462M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...